Hillsdale Investment Management Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Hillsdale Investment Management Inc.
- $1.13 Billion
- Q1 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 39,279 shares of AMPH stock, worth $1.48 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
39,279
Previous 96,353
59.23%
Holding current value
$1.48 Million
Previous $5.96 Million
71.07%
% of portfolio
0.15%
Previous 0.51%
Shares
12 transactions
Others Institutions Holding AMPH
# of Institutions
276Shares Held
33.4MCall Options Held
56.6KPut Options Held
57.3K-
Black Rock Inc. New York, NY6.08MShares$228 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$103 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.08MShares$78.1 Million0.21% of portfolio
-
Neuberger Berman Group LLC New York, NY1.66MShares$62.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.51MShares$56.9 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.84B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...